Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
kolonidannende enhed OG/ELLER stimulerende faktor |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
Bacterial product |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
Blood material |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
Blood derivative (substance) |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
vaccine, immunglobulin OG/ELLER antiserum |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
Collagen |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
Microbial agent (substance) |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
Gelatin (substance) |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
syntetisk copolymer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Product containing glatiramer (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Product containing interleukin-11 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Botulinum toxin type A 500 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Clostridium botulinum 100units powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Product containing Clostridium botulinum toxin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Clostridium botulinum-toxin type A-hæmagglutinin-kompleks |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Agalsidase beta 5 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
glatirameracetat 20 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
biologisk middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Poisoning caused by biological substance |
Causative agent |
False |
biologisk middel |
Inferred relationship |
Some |
|
Product containing oprelvekin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
oprelvekin 5 mg pulver til injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Interleukins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Glatiramer acetate 20mg injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Product containing botulinum toxin type B (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Agalsidase beta 35 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Product containing agalsidase beta (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Clostridium botulinum-toxin type B 5000 enheder/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Clostridium botulinum-toxin type B 5000 enheder/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Clostridium botulinum-toxin type B 5.000 enheder/ml, opløsning til injektion, ampul a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Product containing denileukin diftitox (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Fabrazyme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Glatiramer acetate 20 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
glatirameracetat 20 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Product containing tumor necrosis factor alpha inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
biologisk middel |
Inferred relationship |
Some |
|
Tumor necrosis factor alpha inhibitor |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
Colony stimulating factor (substance) |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|
Collagen + procollagen |
Is a |
False |
biologisk middel |
Inferred relationship |
Some |
|